1. Home
  2. NBIX vs KSPI Comparison

NBIX vs KSPI Comparison

Compare NBIX & KSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$131.62

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

KSPI

Joint Stock Company Kaspi.kz

HOLD

Current Price

$86.55

Market Cap

16.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
KSPI
Founded
1992
2008
Country
United States
Kazakhstan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
16.9B
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
NBIX
KSPI
Price
$131.62
$86.55
Analyst Decision
Strong Buy
Hold
Analyst Count
22
3
Target Price
$180.91
$104.33
AVG Volume (30 Days)
1.1M
550.2K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
8.56%
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$3.90
Revenue Next Year
$13.14
$16.80
P/E Ratio
$28.21
$7.12
Revenue Growth
977.51
N/A
52 Week Low
$108.47
$68.59
52 Week High
$160.18
$99.11

Technical Indicators

Market Signals
Indicator
NBIX
KSPI
Relative Strength Index (RSI) 53.32 60.27
Support Level $124.62 $71.17
Resistance Level $135.30 $93.59
Average True Range (ATR) 3.41 3.51
MACD 0.17 -0.02
Stochastic Oscillator 70.73 40.61

Price Performance

Historical Comparison
NBIX
KSPI

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About KSPI Joint Stock Company Kaspi.kz

Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform, which derives maximum revenue, connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.

Share on Social Networks: